The purpose of this study is to test the effectiveness of Helicoll (a collagen wound dressing) in treating chronic and non-chronic wounds of recessive dystrophic epidermolysis bullosa (RDEB) patients. Helicoll will be compared to standard wound dressings.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Helicoll Collagen I Wound Dressing
Standard of Care wound dressings (e.g. Vaseline gauze)
Stanford School of Medicine
Stanford, California, United States
Percentage of Wound Surface Area Change From Baseline to Week 8
Change was assessed in terms of wound surface area, as measured using the ARANZ camera. Week 8 surface area measurement was compared to baseline surface area measurement and percentage in size change was calculated.
Time frame: Baseline and Week 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.